Immix Biopharma Inc (IMMX)
NASDAQ
Fin d'année 31 Décembre 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -206.363 | -154.821 | -260.346 | -49.728 | -88.571 |
Return on Equity (%) | 53.374 | 27.408 | -367.811 | -52.841 | -105.071 |
Return on Invested Capital (%) | 47.34 | 11.05 | -20.4 | -52.851 | -110.468 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | -1.62 | -2.103 | 1.083 | 0.762 | 0.697 |
Earnings Per Share | -0.432 | -0.51 | -1.469 | -0.477 | -0.664 |
Cash Per Share | 0.326 | 0.174 | 1.063 | 0.778 | 0.753 |
Working Capital Per Share | -1.625 | -2.106 | 1.083 | 0.789 | 0.691 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -0.423 | -0.502 | -1.468 | -0.476 | -0.67 |
EBITDA Per Share | -0.423 | -0.502 | -1.468 | -0.476 | -0.67 |
Free Cash Flow Per Share | -0.43 | -0.511 | -1.469 | -0.477 | -0.662 |
Fin d'année 31 Décembre 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 1,13M | 1,13M | 13,23M | 13,89M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||||
Actions en circulation | 13,89M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 61,89M |
Ratio cours/bénéfice | -4,01 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 3,53 |
Ratio prix/valeur comptable | 3,82 |
Rendement de dividende | - |
Actions en circulation | 27,51M |
Volume moyen (1 semaine) | 74,64k |
Volume moyen (1 mois) | 167,12k |
Variation sur 52 semaines | -65,96% |
Plus haut sur 52 semaines | 6,6699 |
Plus bas sur 52 semaines | 1,26 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales